The debate about treating "low T" in older men will heat up

The debate about treating "low T" in older men will heat up...due to controversy over testosterone's cardiovascular risk.

A recent JAMA study has Health Canada and the FDA investigating a possible link between testosterone therapy and heart attacks and strokes.

Critics say the JAMA study is flawed.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote